| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
cjbscvictory |
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
- Meseclazone
-
- $2500.00
-
2026-05-11
- CAS:29053-27-8
- Purity:
- Supply Ability: 10g
|
| | Meseclazone Basic information |
| Product Name: | Meseclazone | | Synonyms: | 3,3a-Dihydro-7-chloro-2-methyl-2H,9H-isoxazolo[3,2-b][1,3]benzoxazin-9-one;7-Chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo[3,2-b][1,3]benzoxazin-9-one;W-2395;NSC297623;Meseclazone;7-chloro-2-methyl-3,3a-dihydro-2H-[1,2]oxazolo[3,2-b][1,3]benzoxazin-9-one;2H,9H-Isoxazolo[3,2-b][1,3]benzoxazin-9-one, 7-chloro-3,3a-dihydro-2-methyl- | | CAS: | 29053-27-8 | | MF: | C11H10ClNO3 | | MW: | 239.65 | | EINECS: | | | Product Categories: | | | Mol File: | 29053-27-8.mol |  |
| | Meseclazone Chemical Properties |
| Melting point | 148°C | | Boiling point | 131.8°C (rough estimate) | | density | 1.3213 (rough estimate) | | refractive index | 1.5800 (estimate) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | -3.18±0.40(Predicted) |
| | Meseclazone Usage And Synthesis |
| Uses | Anti-inflammatory. | | in vivo | Meseclazone inhibits collagen-induced aggregation 1 and 4 hr after oral administration[1]. Intravenous administration of Meseclazone and other nonsteroidal anti-inflammatory drugs caused a dose-dependent inhibition of bronchoconstriction resulting in the following order of descending potency: isoproterenol congruent to indomethacin greater than fenoprofen greater than tolmetin greater than aspirin greater than naproxen congruent to ibuprofen greater than phenylbutazone greater than diflunisal greater than Meseclazone greater than 5-CSA[2]. |
| | Meseclazone Preparation Products And Raw materials |
|